Literature DB >> 25649697

Plasma corin decreases after coronary artery bypass graft surgery and is associated with postoperative heart failure: a pilot study.

Caryn S Barnet1, Xiaoxia Liu2, Simon C Body2, Charles D Collard3, Stanton K Shernan2, Jochen D Muehlschlegel2, Petr Jarolim4, Amanda A Fox5.   

Abstract

OBJECTIVE: Corin is a natriuretic peptide-converting enzyme that cleaves precursor pro-B-type natriuretic peptide to active B-type natriuretic peptide (BNP) (diuretic, natriuretic, and vasodilatory properties). Increased plasma BNP is a known diagnostic and prognostic heart failure (HF) biomarker in ambulatory and surgical patients. Recent studies indicate that plasma corin is decreased significantly in chronic HF patients, yet perioperative plasma corin concentrations have not been assessed in cardiac surgical patients. The objectives of this study were to determine the effect of coronary artery bypass graft (CABG) surgery with cardiopulmonary bypass (CPB) on plasma corin concentrations and to assess the association between change in perioperative plasma corin concentration and long-term postoperative HF hospitalization or death. It was hypothesized that plasma corin concentrations decrease significantly from preoperative baseline during postoperative days 1 to 4 and that hospitalization or death from HF during the 5 years after surgery is associated with higher relative difference (preoperative baseline to postoperative nadir) in plasma corin concentrations.
DESIGN: Prospective observational pilot study.
SETTING: Two institutions: Brigham and Women's Hospital, Boston, Massachusetts and the Texas Heart Institute, St. Luke's Hospital, Houston, Texas. PARTICIPANTS: 99 patients of European ancestry who underwent isolated primary CABG surgery with CPB.
INTERVENTIONS: Nonemergency isolated primary CABG surgery with CPB.
MEASUREMENTS AND MAIN RESULTS: Plasma corin concentration was assessed preoperatively and at 4 postoperative time points (postoperative days 1-4). HF hospitalization or HF death events during the 5 years after surgery were identified by review of hospital and death records. Postoperative plasma corin concentrations were significantly lower than preoperative baseline concentrations (p<0.0001). Perioperative corin concentrations were significantly higher in males than in females (p<0.0001). Fifteen patients experienced long-term postoperative HF events. Patients who experienced HF hospitalization or HF death during study follow-up had significantly higher relative difference in plasma corin concentration (preoperative baseline to postoperative nadir) than patients who did not experience HF events during study follow-up (p=0.03).
CONCLUSIONS: Plasma corin concentrations decrease significantly from preoperative concentrations after CABG surgery. HF hospitalization or HF death during the 5 years after CABG surgery with CPB is associated with larger relative decrease in plasma corin concentration from preoperative baseline. Further investigation is warranted to determine the role of corin in postoperative HF biology.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  biologic markers; cardiac surgery; corin protein; coronary artery bypass grafting; heart failure; human corin; natriuretic peptide

Mesh:

Substances:

Year:  2014        PMID: 25649697      PMCID: PMC4394899          DOI: 10.1053/j.jvca.2014.11.001

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  26 in total

1.  Corin is present in the normal human heart, kidney, and blood, with pro-B-type natriuretic peptide processing in the circulation.

Authors:  Tomoko Ichiki; Brenda K Huntley; Denise M Heublein; Sharon M Sandberg; Paul M McKie; Fernando L Martin; Michihisa Jougasaki; John C Burnett
Journal:  Clin Chem       Date:  2010-11-12       Impact factor: 8.327

2.  Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage.

Authors:  Kristin N Luckenbill; Robert H Christenson; Allan S Jaffe; Johannes Mair; Jordi Ordonez-Llanos; Franca Pagani; Jillian Tate; Alan H B Wu; Ranka Ler; Fred S Apple
Journal:  Clin Chem       Date:  2008-03       Impact factor: 8.327

3.  Process matters: Emerging concepts underlying impaired natriuretic peptide system function in heart failure.

Authors:  Daniel L Dries
Journal:  Circ Heart Fail       Date:  2011-03       Impact factor: 8.790

4.  Processing of pro-B-type natriuretic peptide: furin and corin as candidate convertases.

Authors:  Alexander G Semenov; Natalia N Tamm; Karina R Seferian; Alexander B Postnikov; Natalia S Karpova; Daria V Serebryanaya; Ekaterina V Koshkina; Mihail I Krasnoselsky; Alexey G Katrukha
Journal:  Clin Chem       Date:  2010-05-20       Impact factor: 8.327

5.  Comparison of the utility of preoperative versus postoperative B-type natriuretic peptide for predicting hospital length of stay and mortality after primary coronary artery bypass grafting.

Authors:  Amanda A Fox; Jochen D Muehlschlegel; Simon C Body; Stanton K Shernan; Kuang-Yu Liu; Tjorvi E Perry; Sary F Aranki; E Francis Cook; Edward R Marcantonio; Charles D Collard
Journal:  Anesthesiology       Date:  2010-04       Impact factor: 7.892

6.  Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association.

Authors:  Paul A Heidenreich; Justin G Trogdon; Olga A Khavjou; Javed Butler; Kathleen Dracup; Michael D Ezekowitz; Eric Andrew Finkelstein; Yuling Hong; S Claiborne Johnston; Amit Khera; Donald M Lloyd-Jones; Sue A Nelson; Graham Nichol; Diane Orenstein; Peter W F Wilson; Y Joseph Woo
Journal:  Circulation       Date:  2011-01-24       Impact factor: 29.690

7.  Decompensated heart failure is associated with reduced corin levels and decreased cleavage of pro-atrial natriuretic peptide.

Authors:  Uzoma N Ibebuogu; Inna P Gladysheva; Aiilyan K Houng; Guy L Reed
Journal:  Circ Heart Fail       Date:  2011-01-07       Impact factor: 8.790

8.  Preoperative B-type natriuretic peptide is as independent predictor of ventricular dysfunction and mortality after primary coronary artery bypass grafting.

Authors:  Amanda A Fox; Stanton K Shernan; Charles D Collard; Kuang-Yu Liu; Sary F Aranki; Stacia M DeSantis; Petr Jarolim; Simon C Body
Journal:  J Thorac Cardiovasc Surg       Date:  2008-08       Impact factor: 5.209

9.  Plasma soluble corin in patients with heart failure.

Authors:  Ningzheng Dong; Shenghan Chen; Junhua Yang; Lizhen He; Peng Liu; Dongdong Zheng; Lin Li; Yiqing Zhou; Changgeng Ruan; Edward Plow; Qingyu Wu
Journal:  Circ Heart Fail       Date:  2010-01-08       Impact factor: 8.790

10.  Simultaneous assessment of unprocessed ProBNP1-108 in addition to processed BNP32 improves identification of high-risk ambulatory patients with heart failure.

Authors:  Daniel L Dries; Bonnie Ky; Alan H B Wu; J Eduardo Rame; Mary E Putt; Thomas P Cappola
Journal:  Circ Heart Fail       Date:  2010-01-27       Impact factor: 8.790

View more
  12 in total

1.  Sex-specific association between soluble corin and metabolic syndrome in Chinese adults.

Authors:  Hongmei Li; Qiu Zhang; Yan He; Jijun Shi; Weidong Hu; Hao Peng
Journal:  Hypertens Res       Date:  2019-02-14       Impact factor: 3.872

Review 2.  Role of corin in the regulation of blood pressure.

Authors:  Hui Li; Yue Zhang; Qingyu Wu
Journal:  Curr Opin Nephrol Hypertens       Date:  2017-03       Impact factor: 2.894

3.  Potential value of circulating corin levels in acute and chronic myocardial infarction.

Authors:  Dong Wang; Guy L Reed
Journal:  J Lab Precis Med       Date:  2017-06-09

4.  Identification and functional analysis of CORIN variants in hypertensive patients.

Authors:  Yue Zhang; Tiantian Zhou; Yayan Niu; Meiling He; Can Wang; Meng Liu; Junhua Yang; Yonghong Zhang; Jianping Zhou; Koichi Fukuda; Jun Qin; Ningzheng Dong; Qingyu Wu
Journal:  Hum Mutat       Date:  2017-09-26       Impact factor: 4.878

5.  Depressed Corin Levels Indicate Early Systolic Dysfunction Before Increases of Atrial Natriuretic Peptide/B-Type Natriuretic Peptide and Heart Failure Development.

Authors:  Ranjana Tripathi; Dong Wang; Ryan Sullivan; Tai-Hwang M Fan; Inna P Gladysheva; Guy L Reed
Journal:  Hypertension       Date:  2015-12-14       Impact factor: 10.190

6.  Increases in plasma corin levels following experimental myocardial infarction reflect the severity of ischemic injury.

Authors:  Dong Wang; Inna P Gladysheva; Ryan D Sullivan; Tai-Hwang M Fan; Radhika M Mehta; Ranjana Tripathi; Yao Sun; Guy L Reed
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

7.  Corin Overexpression Reduces Myocardial Infarct Size and Modulates Cardiomyocyte Apoptotic Cell Death.

Authors:  Ryan D Sullivan; Aiilyan K Houng; Inna P Gladysheva; Tai-Hwang M Fan; Ranjana Tripathi; Guy L Reed; Dong Wang
Journal:  Int J Mol Sci       Date:  2020-05-14       Impact factor: 5.923

8.  Association of Factor V Leiden With Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant Data.

Authors:  Lars Wallentin; Folkert W Asselbergs; Riyaz S Patel; Bakhtawar K Mahmoodi; Vinicius Tragante; Marcus E Kleber; Michael V Holmes; Amand F Schmidt; Raymond O McCubrey; Laurence J Howe; Kenan Direk; Hooman Allayee; Ekaterina V Baranova; Peter S Braund; Graciela E Delgado; Niclas Eriksson; Crystel M Gijsberts; Yan Gong; Jaana Hartiala; Mahyar Heydarpour; Gerard Pasterkamp; Salma Kotti; Pekka Kuukasjärvi; Petra A Lenzini; Daniel Levin; Leo-Pekka Lyytikäinen; Jochen D Muehlschlegel; Christopher P Nelson; Kjell Nikus; Anna P Pilbrow; W H Wilson Tang; Sander W van der Laan; Jessica van Setten; Ragnar O Vilmundarson; John Deanfield; Panos Deloukas; Frank Dudbridge; Stefan James; Ify R Mordi; Andrej Teren; Thomas O Bergmeijer; Simon C Body; Michiel Bots; Ralph Burkhardt; Rhonda M Cooper-DeHoff; Sharon Cresci; Nicolas Danchin; Robert N Doughty; Diederick E Grobbee; Emil Hagström; Stanley L Hazen; Claes Held; Imo E Hoefer; G Kees Hovingh; Julie A Johnson; Marcin P Kaczor; Mika Kähönen; Olaf H Klungel; Jari O Laurikka; Terho Lehtimäki; Anke H Maitland-van der Zee; Ruth McPherson; Colin N Palmer; Adriaan O Kraaijeveld; Carl J Pepine; Marek Sanak; Naveed Sattar; Markus Scholz; Tabassome Simon; John A Spertus; Alexandre F R Stewart; Wojciech Szczeklik; Joachim Thiery; Frank L J Visseren; Johannes Waltenberger; A Mark Richards; Chim C Lang; Vicky A Cameron; Axel Åkerblom; Guillaume Pare; Winfried März; Nilesh J Samani; Aroon D Hingorani; Jurriën M Ten Berg
Journal:  Circulation       Date:  2020-07-13       Impact factor: 29.690

9.  Low serum corin levels predict end-organ damage in patients with hypertensive crisis.

Authors:  Burcu Genç Yavuz; Özgür Söğüt; Şahin Çolak; Macit Koldaş; Esma Yücetaş; Okan Bari
Journal:  Anatol J Cardiol       Date:  2021-08       Impact factor: 1.596

10.  Corin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy.

Authors:  Aiming Pang; Yahui Hu; Pengfei Zhou; Guangfeng Long; Xin Tian; Li Men; Yanna Shen; Yunde Liu; Yujie Cui
Journal:  Cardiovasc Diabetol       Date:  2015-10-07       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.